Alimera Sciences Q4 EPS $(0.07) Up From $(0.54) YoY, Sales $26.31M Beat $24.34M Estimate
Alimera Sciences Q4 EPS $(0.07) Up From $(0.54) YoY, Sales $26.31M Beat $24.34M Estimate
Alimera Sciences第四季度每股收益美元（0.07美元）高於同比（0.54美元），銷售額2631萬美元超過預期的2434萬美元
Alimera Sciences (NASDAQ:ALIM) reported quarterly losses of $(0.07) per share. This is a 87.04 percent increase over losses of $(0.54) per share from the same period last year. The company reported quarterly sales of $26.31 million which beat the analyst consensus estimate of $24.34 million by 8.08 percent. This is a 87.51 percent increase over sales of $14.03 million the same period last year.
Alimera Sciences（納斯達克股票代碼：ALIM）報告稱，季度每股虧損爲0.07美元。與去年同期每股虧損0.54美元（0.54）相比，增長了87.04％。該公司公佈的季度銷售額爲2631萬美元，比分析師普遍預期的2434萬美元高出8.08％。這比去年同期的1,403萬美元銷售額增長了87.51％。